This is a StreetInsider.com Premium Only Page

Sorrento Therapeutics (SRNE) – Management Comments

Aug 24, 2021 10:45 AM Sorrento Therapeutics (SRNE) Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University

Aug 11, 2021 08:37 AM Dyadic (DYAI) and Sorrento (SRNE) Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeu

Jun 2, 2021 07:13 AM

Apr 20, 2021 09:01 AM

Apr 5, 2021 09:01 AM

Mar 2, 2021 09:07 AM

Jan 27, 2021 06:11 AM

Nov 11, 2020 09:01 AM

Oct 12, 2020 05:24 PM

Oct 7, 2020 03:11 PM

Oct 7, 2020 06:13 AM

Sep 22, 2020 02:30 PM

Sep 17, 2020 06:35 AM

Sep 14, 2020 06:18 AM

Aug 20, 2020 04:06 PM

Aug 19, 2020 09:01 AM

Jul 24, 2020 09:01 AM

Jul 1, 2020 12:06 PM

May 15, 2020 11:01 AM

Apr 2, 2020 12:37 PM

Jan 29, 2020 07:20 AM

Nov 25, 2019 07:01 AM

Jun 19, 2019 07:02 AM

Jun 4, 2019 07:02 AM

Mar 26, 2019 08:33 AM

Mar 22, 2019 07:01 AM

Mar 11, 2019 07:18 AM

Jan 22, 2019 07:07 AM

Jan 14, 2019 07:16 AM

Nov 6, 2018 09:11 AM

Nov 1, 2018 08:01 AM

Sep 10, 2018 05:54 AM

Aug 13, 2018 05:47 AM

Jul 3, 2018 09:33 AM

Apr 5, 2018 02:54 PM

Mar 19, 2018 08:10 AM

Feb 28, 2018 02:12 PM

Jan 29, 2018 08:10 AM

Jan 2, 2018 08:12 AM

Oct 2, 2017 08:02 AM

Sep 12, 2017 06:11 AM

Jun 14, 2017 09:06 AM

May 4, 2017 09:46 AM

Nov 16, 2016 03:26 PM

Nov 8, 2016 04:26 PM

Aug 16, 2016 05:49 AM

Aug 8, 2016 09:12 AM

Aug 2, 2016 09:04 AM

Jul 11, 2016 09:01 AM

May 16, 2016 07:05 AM